期刊文献+

脊髓损伤实验治疗的方向和策略 被引量:6

原文传递
导出
摘要 脊髓损伤(SCI)的治疗一直是困扰医学界的一个难题,经过科学家们不懈的努力,取得了多方面的令人兴奋的进展,使我们有了更深的认识,从而指导现代实验治疗的策略.SCI方面内容繁杂,本文拟以近几年来引人关注的一些突破性进展为重点,对SCI实验治疗的方向和策略进行分析概述.
作者 祁全 毕郑钢
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2005年第12期1599-1601,共3页 Chinese Journal of Experimental Surgery
  • 相关文献

参考文献23

  • 1Dumant RJ, Okonkwo 130, Verma S, et al.Acute spinal cord injury, part Ⅰ : pathophysiologic mechanisms. Clin Neuropharmacol,2001,24:254-264.
  • 2Ehud H, Amalia G, Avi C, et al. Vaccination with dendritic cells pulsed with peptides of yelin basic protein promotes functional recovery from spinal cord injury. J Neurosci,2003, 23:8808-8819.
  • 3Hauben E, Agranov E, Gothilf A, et al.Posttraumatic therapeutic vaccination with modified yelin self-antigen prevents complete paralysis while avoiding autoimmune disease. J Clin Invest, 2001, 108:591-599.
  • 4Prinjha R, Morrow SE, Vinson M, et al. Inhibitor of neurite outgrowth in humans. Nature, 2000, 403 : 383-384.
  • 5Fournier AE, Grandpre T, Strittmatter SM.Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature, 2001,409 : 341-346,.
  • 6Brian K, Jaimie F, Wolfram T. Molecular targets for therapeutic intervention after spinal cord injury. Mol Interv, 2002, 2 : 244-258.
  • 7Shuxin L, Betty P, Stephane B, et al. Blockade of Nogo-66, Myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury. J Neurosci, 2004, 24 : 10511-10520.
  • 8Zampieri N, Chao MV. The p75 NGF receptor exposed. Science, 2004, 304: 833-834.
  • 9Alyson E, Bayan T, Stephen M. Rho kinase inhibition enhances axonal regeneration in the injured CNS. J Neurosci, 2003, 23:1416-1425.
  • 10Sivasankaran R, Pei J, Wang KC, et al. PKC mediates inhibitory effects of myelin and chondroitin sulfate proteoglycans on axonal regeneration. Nat Neurosci, 2004, 7: 261-268.

二级参考文献3

共引文献20

同被引文献61

引证文献6

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部